What is the Ownership and Shareholding Structure of Theon Pharmaceuticals?
In 2023, Theon Pharmaceuticals had a promoter holding of 63.86% and a public holding of 36.14%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.











Company Details
+91-XXXXXXXXXX